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1179-76 The National Cholesterol Education Program Guidelines 
Underestimate Disease Risk in Young Adults 
Kwame O. Akosah. Ana M, Schaper, Sharon Barnhart, Paul Havlik, Christopher Cogbill, 
Paul M. Schoenfald, Gundersen Lutheran, LaCrosse, Wisconsin. 
Background: Recent trials suggest that there has been improvement in secondary pre- 
vention and that age-adjusted mortality rates following myocardial infarction (MI) have 
declined. However, preventing coronary heart disease (CHD) in the first place remains a 
challenge. The recently published National Cholesterol Education Program (NCEP) 
guidelines (Adult Treatment Panel III) result in identifying more patients for treatment. Its 
applicability to specific populations at risk is not known. We sought to determine how well 
this model determines risk status for young adults. 
Objective: To evaluate the ability of the new guidelines to classify risk status in men _< age 
55 years and women _< age 65 years. 
Method: A retrospective chart review of cardiovascular risk factors in a population of 
young adults admitled with MI. Patients with a previous history of CHD or CHD equiva- 
lent were excluded. Risks of ten-year probability for a CHD event were calculated. 
Patients meeting criteria for drug therapy were stratified by LDL cholesterol levels. 
Results: In a 3-year period, 284 patients were admitted with MI, 222 of whom met criteria 
by not having a previous history of CAD or equivalent. The mean age was 50 years; 75% 
were male. The mean LDL cholesterol level was 126 mg/dL. Of this population, 50% had 
0-1 risk factor, of whom only 8% had LDL >160 and would have met criteria for treatment. 
Among patients with 2 risk factors and a 10-year risk <10% (61 patients), only 2% met 
criteria for treatment. There were 29 patients with 2 risk factors and a risk of 10-20%, of 
whom 45% met criteria to be treated. Of the patients with > 20% risk (n = 21), 91% would 
have been treated. Overall, per the new guidelines, as many as 74% of young adults pre- 
senting with an MI would not have met criteria for drug management if seen by their phy- 
sician at some time prior to their event. 
Conclusion: The new guidelines are an improvement in identifying more candidates for 
primary prevention. However, many young adults at risk for an imminent MI are not iden- 
tified. The reason is that a significant number of young adults presenting with MI have 
few risk factors and do not have high LDL cholesterol levels. Primary prevention must 
focus on reduction of all identifiable risk factors. 
1179-77 The Metabol ic  Score Predicts Subclinical 
Atherosclerosls Independent of Fasting Serum LDL: 
Evidence Supporting Inclusion of the Metabolic 
Syndrome as a Component Within the NCEP ATP III 
Guidelines 
Marc E. Hunt. Patrick G. O'Malley, Irwin Feuerstein, Affen J. Taylor, Walter Reed Army 
Medical Center, Washington, Dist. of Columbia. 
Background: The metabolic syndrome is a constellation of modifiable lipid and non-lipid 
risk factors promoted by NCEP ATP III for the identification of subjects at increased risk 
for future cardiovascular events. We compared the prevalence of subclinical atheroscle- 
rosis in subjects with and without he metabolic syndrome to determine its contribution to 
the cardiovascular dsk assessment in esymptomatic screening populations. 
Methods: We studied 999 consecutive, asymptomatic, healthy subjects, ages 40-45 yrs, 
enrolled in a prospective cardiovascular risk assessment study. The "metabolic score" 
was calculated as the sum of the five following risk factors (present or absent; defined 
per NCEP lif): HTN, abdominal obesity, fasting serum glucose, elevated total cholesterol 
and depressed HDL-C. The metabolic syndrome was defined as a metabolic score >3. 
Coronary artery calcification (CAC) on EBCT was used to measure subclinical athero- 
sclerosis. 
Results: The prevalence of the metabolic syndrome was 8.9% (89/999). Subjects with 
the metabolic syndrome had significantly higher fasting insulin levels and lower physical 
activity indices. The prevalence of a positive CAC score was 17.2% (172/999) and sub- 
jects with the metabolic syndrome were more likely to have a positive CAC score 24.7% 
(22/89) compared to those without 16.5% (150/910, p<0.05.) Furthermore, the presence 
of a positive CAC score significantly varied across the range of metabolic scores (from 
14.1% for MS = 0, to 38.5% with MS >_4; p=0.009). After controlling for serum LDL-C, the 
metabolic score remained a significant predictor of subclinical atherosclerosis. 
Concluelon: Calculation of the =metabolic score" is a simple, readily attainable clinical 
measurement hat directly and independently relates to the likelihood of premature sub- 
clinical calcified atherosclerosis in an asymptomatic screening population. Treatment of 
the metabolic syndrome through weight loss, promotion of physical activity and treatment 
of individual risk factors has the potential to retard progression of the atherosclerotic bur- 
den beyond the benefits of LDL reduction alone. 
1179-78 Adult High Density Liporotein Cholesterol Has 
Decreased Ten Percent in the Past 25 Years: The 
Princeton Follow-Up Study 
John A. Morrison. Bruce A. Barton, Sprecher L. Sprecher, Lisa A. Friedman, Children's 
Hospital Medical Center, Cincinnati, Ohio, Maryland Medical Research Institute, 
Baltimore, Maryland. 
Background: The major anti-atherogenic factor, HDL-C, correlates positively with satu- 
rated fat intake and negatively with both smoking and obesity. During the past 25 years 
public health efforts and clinical practice have promoted cardiovascular risk modification; 
addressing especially diet and smoking. 
Methods: To examine intergenerational changes in these factors and possible changes in 
HDL-C in black and white adults, we compared parent participants from the Lipid 
Research Clinics (LRC) Princeton Prevalence Program, 1973-76, with LRC children-par- 
ticipants, currently being retested as part of the Princeton LRC Follow-up Study. Compar- 
isons were restricted to 27-47 year-old participants in each generation (G) for 
comparability, including 760 G1 and 571 G2. Diet was assessed using 24-hour recall in 
the LRC study and Block Quantified Food Frequency in the Follow-up study. Smoking 
was determined by questionnaire, and obesity by the body mass index (BMI = kg/m2). 
Mean factor levels and percentages (%) of participants above established cutpoints were 
compared using pooled t-tests and likelihood ratio chi square analyses. 
Results: The prevalence of smoking was significantly lower in G2 than in G1, overall (26 
v 42%) and in each sex-race group. Mean % of calories from fat (37 v 40%) and satu- 
rated fat (11 v 15%) were significantly lower in G2 than in G1, overall and in whites. Mean 
BMt and the % of participants > 30 BMI were significantly greater in G2, overall and in 
each sex race group. The effects of these, and other changes, is lower mean HDL-C lev- 
els in G2 than G1 members, overall (45.8 vs 50.8 mg/dl) and in each subgroup. In addi- 
tion, the percentage of parents with clinically defined low HDL-C (< 35 mg/dl) was 
significantly higher overall and in each subgroup. 
Conclusions: Despite the marked decreases in the prevalence of smoking, which should 
lead to increased HDL-C, decreases in saturated fat intake (which is beneficial for LDL- 
C) and the increase in obesity has contributed to markedly lower HDL-C in black and 
white young and middle-aged adults. More effective approaches to weight management 
are needed. 
1179-79 Secondary Prevention Is Infer ior  in Pat ients  With 
Peripheral Arterial Disease 
Pavel J. Levv. Kristen MacClenahan, Carlos M. Ferrario, Carla Yunis, Wake Forest 
University School of Medicine, Winston-Salem, North Carolina. 
Background: Coronary (CAD) and peripheral (PAD) atherosclerotic disease share the 
same risk factors and, presumably have similar secondary prevention strategies. We 
hypothesized that patients with PAD are less likely to be adequately managed for sec- 
ondary prevention. 
Methods and Results: Cardiovascular risk factors, use of lipid-lowering therapy (LLT) and 
aspirin were compared in CAD and PAD patients referred for their first interventional pro- 
cedure at a singFe tertiary care center. We performed a retrospective chart review of a 
random sample of patients undergoing either CABG (n=180) or lower extremity revascu- 
larization (n=180) between 1994 and 1999. All abstracted clinical information was avail- 
able prior to the patient's first surgical intervention. Patients in both groups were of 
comparable age (67 ± 10 yrs) and ethnicity (91% White), and had similar low use of LLT 
(CAD=26%, PAD=20%). Compared to CAD subjects, the PAD group had greater fre- 
quency of women (OR=1.7; 95% CI: 1.1-2.7; p=0.02) and current smokers (OR=3.8; 95% 
CI: 2.1-6.9; p=0.001). PAD subjects had lower use of aspirin (OR=0.4; 95% CI: 0.3-0.7; 
p=0.001) and in only 6% of the sample lipid abnormalities were evaluated, compared to 
71% in the CABG group. Both aspirin use (OR=2.4; 95% CI: 1.2-4.6; p=0.03) and LLT 
(OR=4.5; 95% CI: 1.2-18.4; p=0,02) were strongly associated with a previous history of 
CAD in subjects with PAD. 
Conclusion: PAD patients are less likely to have a lipid profile performed, to succeed with 
smoking cessation initiatives, and to be on aspirin. These findings may reflect the lack of 
standardized clinical management guidelines, and lower awareness regarding secondary 
prevention of PAD. 
1179-80 Considering Lipids as a Vital Sign: A New Model for the 
Rapid and Effective Del ivery of  Coronary Prevention 
Management Using Point of Care Testing 
Stephen Devries. Maria Ayata, Jennifer Breadhurst, Marcie Chantaparanont, Mary 
Conroy, Julie Esguerra, Beulah Jefferson, Mary McGarrigle, Olga Pineda, Marianne 
Riley-Jensen, Patrice Spinella, University of Illinois at Chicago, Chicago, Illinois. 
Background: This abstract describes the organization and outcomes of a system for 
lipid management based on point of care cholesterol testing. Point of care testing, as uti- 
lized in our model, permits lipid values to be immediately available for evaluation at the 
time of each clinical encounter- regardless of the reason for consultation. Lipid results 
are recorded on the intake form alongside the blood pressure and pulse, and in so doing, 
are considered a "vital sign" for coronary prevention. 
Methods: All new patients referred to the outpatient cardiology clinic are encouraged to 
have lipid measurements performed at the time of their first visit. Cholesterol testing is 
performed with a capillary blood sample in 5 minutes using a bench top analyzer previ- 
ously validated for accuracy and precision. If a lipid abnormality is identified, patients are 
prescribed lifestyle and diet recommendations, which are reinforced by the nurse at the 
time of discharge. Patients are then instructed to return to the cardiology clinic point of 
care lab in 6-12 weeks, where repeat lipids are run and management directed by a rotat- 
ing team of highly skilled and motivated nurses. Management is based on NCEP guide- 
lines. Return visits for those on lipid lowering therapy are arranged at intervals no greater 
than 4 months. 
Results: In the 5 years since the point of care model was adopted, in excess of 12,000 
lipid measurements have been performed. Among patients followed over the last 2 
years, 88% were at or within 10% of their NCEP recommended goal for LDL cholesterol. 
Most importantly, among those patients at their NCEP goal in 2000, 93% remained at or 
within 10% of their goal in 2001. The time required for return visits, including blood draw- 
ing, lipid analysis and counseling, was 17 ± 1 (SE) minutes (n=100). 
Conclusion: A new process for lipid management is described featuring a collaborative 
nurse/physician team utilizing point of care lipid testing. This model has the potential for 
broad applicability and has been demonstrated to deliver preventive care rapidly, effec- 
tively, and with sustained results. 
